Firm
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Jennifer Che explains how taking on the managing director role at her firm has offered a new perspective, and why Hong Kong is seeing a life sciences boom
Sponsored
Sponsored
-
Sponsored by TOPPAN Digital IPManaging IP hears how TOPPAN Digital IP’s platform aims to streamline global patent management, combining artificial intelligence and human expertise to facilitate efficient filings, accurate translations, and smooth renewals in a single, secure environment -
Sponsored by Licks AttorneysHow UK extraterritorial decisions are undermining Brazilian judicial sovereignty and violating TRIPSSenior patent attorneys at Licks Attorneys say recent UK court decisions on FRAND licensing conflict with Brazilian judicial sovereignty and the TRIPS framework governing the territorial independence of patents
-
Sponsored by Gün and PartnersSelin Sinem Erciyas of Gün + Partners explores the growing alignment between Turkish courts and the Unified Patent Court in applying a strictly technical-functional standard for patent infringement by equivalence
-
Sponsored by Liu, Shen & AssociatesWenjing Zhu of Liu, Shen & Associates explains how China’s administrative adjudication system is reshaping patent enforcement, offering faster, cost-effective, and technically expert resolutions for patentees, while preserving rights to pursue court remedies
-
Sponsored by Wanhuida Intellectual PropertyMinnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
-
Sponsored by InventaVítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
